10 min read

Phoenix APOE4: Don't judge your progress by p-tau217 and what to track instead

Retesting it to see if your protocol works? Dr. Heather Sandison on what to watch instead, and where to start.

Dr. Kevin Tran

Phoenix APOE4: Don't judge your progress by p-tau217 and what to track instead

Key takeaways · TL;DR

Retesting it to see if your protocol works? Dr. Heather Sandison on what to watch instead, and where to start.

You carry APOE4. You've changed your diet, your sleep, your supplements. Then you retest p-tau217 to see if it's working.

It went up. Or it went down. Now what?

I put that to Dr. Heather Sandison, the author of Reversing Alzheimer's, founder of Solcere Health Clinic and Marama, and one of the most practical voices in Alzheimer's prevention.

We do not know how to interpret serial markers of p-tau217. Nobody knows how. Not a neurologist, not me.

Prefer to watch? The full conversation, APOE4: Which Biomarkers Matter, and What p-tau217 Can't Tell You, is here:

Don't judge your progress by p-tau217

Up or down, a change in one person's p-tau217 can't be read yet. So it can't tell you whether what you're doing is working.

What Heather watches instead:

Your cognition. I think we shouldn't use surrogate markers.

How you think. How you sleep. Whether you feel vital. "That's what really matters."

To be precise: across large groups, p-tau217 is a real risk signal. It isn't a progress marker for one person. And Heather says it shouldn't be used as a screening test on its own: plenty of people with a raised result never develop Alzheimer's.

Should you get a baseline? Her test is what the number does to you. If data makes you more proactive, measure it. If a result would keep you up for weeks, skip it.

Want the full picture before you order anything? Our free APOE4 Brain Biomarker Guide explains what p-tau217, NfL and GFAP can and can't tell you.

Where to start: pick one thing

So if not a number, where do you begin? Heather starts every person with one change, from one of two places.

The big lever you already know is your weakest point. For some people it's sitting all day. For others, sugar and fast food. For others, sleep: waking up tired, insomnia, snoring nobody has checked.

Or something easy. Book the sleep doctor. Start noticing how many carbs you actually eat. Say yes to one more social invitation.

Why easy counts: a win next week is what gets you to the next change.

Do you need to swap every product in your house?

The question Phoenix members reacted to most: is replacing every cleaning product, cosmetic and toiletry worth it, next to sleep, food and exercise?

Heather's test is where it comes from. Swapping out of fear ("if I don't switch my makeup, I'll cause Alzheimer's") raises cortisol and doesn't help you. Swapping because it makes you feel in control is a different thing.

And you don't have to do it this weekend:

If you just wait for your deodorant to run out and then look for the healthier deodorant, that's okay too.

Trying keto? Test, don't guess

Heather thinks everyone at risk should get into ketosis at least once, and try again if it's been years (she says menopause can change how you respond).

If you do:

  • Measure blood ketones. Not breath meters, not urine strips.

  • Before you start: HbA1c, fasting insulin, hsCRP and a lipid panel.

  • Recheck lipids at about 12 weeks. Give it about three months.

  • Watch your thinking and your sleep. Her own tell: in ketosis she's up and ready at 5 a.m.

And measure your food, not the label. Her matcha blend says zero carbohydrates on the back. It spikes her blood sugar to 170 every time. A continuous glucose monitor caught it.

One firm exception: if you've ever had an eating disorder, she says don't count or restrict carbs.

What if keto pushes your LDL or ApoB up?

Heather doesn't stop by reflex. If you clearly feel and think better, she keeps the benefit and works on the cholesterol risk with your doctor. If keto makes you feel awful, she drops the carb restriction and keeps the Mediterranean diet.

(The lipid-lowering options she mentions, from statins to ezetimibe, are decisions for your prescriber.)

Coming up next: Dr. Michael Davidson

My next conversation, recorded on Tuesday 17 November, is with Dr. Michael Davidson, the CEO of NewAmsterdam Pharma, on cholesterol and the APOE4 brain. His company is developing obicetrapib, a cholesterol-lowering pill I explained in a video and full write-up.

Obicetrapib is not approved for Alzheimer's, and this is not a recommendation to take it.

Phoenix members put their questions to him before the recording. I'll tell you the day it's out.

The episode is free. So why join?

The answers are free. The questions came from members.

The toxin question above wasn't mine. A Phoenix member asked it in our community. Other carriers reacted, it rose to the top, and I put it to Heather in the first ten minutes.

That's how the interviews work inside Phoenix. Right now, members are posting their questions for Jodi Scott on stress and everyday exposures, until Sunday 22 November.

Next time, it can be your question.

What you're actually joining

Phoenix is the app and community helping APOE4 carriers beat the odds. Inside, you:

  • Bring your questions to experts in APOE4 and brain health, before each interview is recorded.

  • Build your personal protocol, with a quick daily check-in and a monthly review, so you know what to do next and whether it's working.

  • Track progress through bloodwork, supported wearable data and how you feel, not one number. Bring your own blood tests and see them read against APOE4-specific ranges, not generic "normal".

  • Join your pod: a small group of APOE4 carriers with similar monthly goals, matched each month to help each other stay on track.

Watch how you actually think and feel, the way Heather says. Then have people around you who keep you going.

Let's build your APOE4 protocol together.

For carriers who are serious about beating the odds.

Cheers,

Kevin

P.S. I carry two copies of APOE4. I built Phoenix because I wanted to give myself the best chance of beating the odds. Now I'm building it for you too. Give it sixty days. If you don't feel Phoenix was worth it, tell me and I'll refund you myself. Apply to join Phoenix

Educational, not medical advice. Take this to your own clinician. APOE4 is a risk factor, not a diagnosis.

Sources: Insel PS, et al. Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease. JAMA Neurol 2025;82(10):985–993. PMID 40853684. · Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings. Alzheimers Dement 2025. PMID 40729527.

Dr. Kevin Tran
About the Author

Dr. Kevin Tran

Doctor of Pharmacy

Dr. Kevin Tran is a Doctor of Pharmacy and APOE4/4 carrier dedicated to helping others with the APOE4 gene variant take proactive steps for their health. He founded The Phoenix Community to provide evidence-based resources and support for APOE4 carriers.

View all articles→
Share

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

Do you need to swap every product in your house?
The question Phoenix members reacted to most: is replacing every cleaning product, cosmetic and toiletry worth it, next to sleep, food and exercise? Heather's test is where it comes from. Swapping out of fear ("if I don't switch my makeup, I'll cause Alzheimer's") raises cortisol and doesn't help you. Swapping because it makes you feel in control is a different thing. And you don't have to do it this weekend: If you just wait for your deodorant to run out and then look for the healthier deodorant, that's okay too. Her answer, 06:03
What if keto pushes your LDL or ApoB up?
Heather doesn't stop by reflex. If you clearly feel and think better, she keeps the benefit and works on the cholesterol risk with your doctor. If keto makes you feel awful, she drops the carb restriction and keeps the Mediterranean diet. (The lipid-lowering options she mentions, from statins to ezetimibe, are decisions for your prescriber.) Her answer, 22:52
The episode is free. So why join?
The answers are free. The questions came from members. The toxin question above wasn't mine. A Phoenix member asked it in our community. Other carriers reacted, it rose to the top, and I put it to Heather in the first ten minutes. That's how the interviews work inside Phoenix. Right now, members are posting their questions for Jodi Scott on stress and everyday exposures, until Sunday 22 November. Next time, it can be your question.
What you're actually joining
Phoenix is the app and community helping APOE4 carriers beat the odds. Inside, you: Bring your questions to experts in APOE4 and brain health, before each interview is recorded. Build your personal protocol , with a quick daily check-in and a monthly review, so you know what to do next and whether it's working. Track progress through bloodwork, supported wearable data and how you feel , not one number. Bring your own blood tests and see them read against APOE4-specific ranges, not generic "normal". Join your pod: a small group of APOE4 carriers with similar monthly goals, matched each month to help each other stay on track. Watch how you actually think and feel, the way Heather says. Then have people around you who keep you going. Let's build your APOE4 protocol together. For carriers who are serious about beating the odds. Apply to join Phoenix Cheers, Kevin P.S. I carry two copies of APOE4. I built Phoenix because I wanted to give myself the best chance of beating the odds. Now I'm building it for you too. Give it sixty days. If you don't feel Phoenix was worth it, tell me and I'll refund you myself. Apply to join Phoenix Educational, not medical advice. Take this to your own clinician. APOE4 is a risk factor, not a diagnosis. Sources: Insel PS, et al. Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease. JAMA Neurol 2025;82(10):985–993. PMID 40853684 . · Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings. Alzheimers Dement 2025. PMID 40729527 .
Keep reading

More to explore.

Free download

The Essential Guide to Thriving with APOE4

Explore daily choices and the evidence behind them.

Free emails from Dr. Kevin Tran and Phoenix, a community of 5,000+ APOE4 carriers. Unsubscribe whenever you like.